Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency
Condition(s):Severe Combined ImmunodeficiencyLast Updated:October 8, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Severe Combined ImmunodeficiencyLast Updated:October 8, 2020Unknown status
Condition(s):Severe Combined ImmunodeficiencyLast Updated:September 4, 2014Unknown status
Condition(s):Artemis (DCLRE1C ) Deficient Severe Combined ImmunodeficiencyLast Updated:November 27, 2023Recruiting
Condition(s):Severe Combined Immunodeficiency, AtypicalLast Updated:July 24, 2018Completed
Condition(s):Severe Combined ImmunodeficiencyLast Updated:June 8, 2023Active, not recruiting
Condition(s):Severe Combined Immunodeficiency; Neonatal ScreeningLast Updated:January 5, 2022Completed
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:September 28, 2021Completed
Condition(s):Severe Combined ImmunodeficiencyLast Updated:May 20, 2009Completed
Condition(s):Severe Combined Immunodeficiency, X-LinkedLast Updated:October 12, 2023Recruiting
Condition(s):Severe Combined ImmunodeficiencyLast Updated:February 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.